This bibliography contains links to literature and PubMed abstracts on topics related to ADPKD, including diagnostic guidelines, disease manifestations, morbidity and mortality, and literature reviews.
These publications were chosen by Sanofi Genzyme Medical Affairs personnel. Additional resources on these topics are available and should be investigated.
Irazabal MV, Rangel LJ, Bergstralh EJ et al. Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials. J Am Soc Nephrol. 2015 Jan;26(1):160-72.
Grantham JJ, Torres VE, Chapman A et al. Volume progression in polycystic kidney disease. N Engl J Med. 2006 May 18;354(20):2122-30.
Chapman AB, Bost JE, Torres VE et al. Kidney volume and functional outcomes in autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol. 2012 Mar;7(3):479-86.
Bae KT, Zhou W, Shen C, et al. Growth Pattern of Kidney Cyst Number and Volume in Autosomal Dominant Polycystic Kidney Disease. Clin J Am Soc Nephrol. 2019 Jun 7;14(6):823-833.
Cornec-Le Gall E, Alam A, Perrone RD. Autosomal dominant polycystic kidney disease. Lancet. 2019 Mar 2;393(10174):919-935.
Natoli TA, Smith LA, Rogers KA et al. Inhibition of glucosylceramide accumulation results in effective blockade of polycystic kidney disease in mouse models. Nat Med. 2010 Jul;16(7):788-92.
Natoli TA, Modur V, Ibraghimov-Beskrovnaya O. Glycosphingolipid metabolism and polycystic kidney disease. Cell Signal. 2020 May;69:109526.